Xie J M, Wang Y, Greenberg S S
Department of Physiology, UMDNJ-New Jersey Medical School, Newark.
Blood Vessels. 1991;28(6):475-89. doi: 10.1159/000158894.
SKF-525A (proadifen) inhibits endothelium-dependent relaxations induced by acetylcholine, arachidonic acid and the calcium ionophore A23187. This suggests that SKF-525A is an inhibitor of endothelium-derived relaxing factor (EDRF) and that EDRF may be a product of arachidonic acid metabolism formed via a cytochrome P-450-dependent pathway or that EDRF release is dependent on cytochrome P-450. We tested this postulate using both isolated rings of rat thoracic aorta and dog mesenteric and femoral artery and the perfusion-superfusion bioassay. Rings of rat thoracic aorta and dog mesenteric and femoral artery with intact endothelium were precontracted with an EC50 concentration of norepinephrine (0.1 nmol/l) or U46619 (0.05 mumol/l) and the relaxation to acetylcholine (ACh), bradykinin, adenosine triphosphate (ATP) or nitroglycerin (GTN) were obtained before, 30 min after addition of, and 30 min after washout of SKF-525A (50 mumol/l). SKF-525A inhibited ACh-induced endothelium-dependent relaxation of rat aortic rings and endothelium-dependent relaxation of the dog mesenteric and femoral artery produced by ACh and ATP, but did not affect relaxation to bradykinin or GTN. The inhibitory effect on SKF-525A on ACh and ATP-induced relaxation was partially reversed upon its washout from the muscle chamber. Pretreatment of the blood vessels with ibuprofen (1 mumol/l) did not attenuate SKF-525A-mediated inhibition of the relaxations to any agonist. Selective exposure of dog femoral artery (donor) to SKF-525A (50 mumol/l) for 60 min did not affect the relaxation responses of endothelium-rubbed coronary artery (bioassay tissue) to basal EDRF nor to the effluent from donor tissues stimulated with ACh (10-1,000 pmol), ATP (1-100 nmol) or bradykinin (3-100 pmol). The results show that SKF-525A exhibited a reversible inhibition of endothelium-dependent relaxation by a smooth muscle mechanism unrelated to the generation of EDRF from endothelium.
SKF - 525A(丙磺舒)可抑制乙酰胆碱、花生四烯酸及钙离子载体A23187诱导的内皮依赖性舒张反应。这表明SKF - 525A是内皮源性舒张因子(EDRF)的抑制剂,且EDRF可能是经由细胞色素P - 450依赖性途径形成的花生四烯酸代谢产物,或者EDRF的释放依赖于细胞色素P - 450。我们使用大鼠胸主动脉、犬肠系膜动脉和股动脉的离体血管环以及灌注 - 再灌注生物测定法对这一假设进行了验证。将具有完整内皮的大鼠胸主动脉、犬肠系膜动脉和股动脉血管环用半数有效浓度的去甲肾上腺素(0.1 nmol/L)或U46619(0.05 μmol/L)预收缩,然后在加入SKF - 525A(50 μmol/L)之前、加入后30分钟以及洗脱后30分钟分别检测对乙酰胆碱(ACh)、缓激肽、三磷酸腺苷(ATP)或硝酸甘油(GTN)的舒张反应。SKF - 525A抑制了ACh诱导的大鼠主动脉环内皮依赖性舒张以及ACh和ATP引起的犬肠系膜动脉和股动脉内皮依赖性舒张,但不影响对缓激肽或GTN的舒张反应。当SKF - 525A从肌肉腔中洗脱后,其对ACh和ATP诱导舒张的抑制作用部分逆转。用布洛芬(1 μmol/L)预处理血管并未减弱SKF - 525A介导的对任何激动剂诱导舒张的抑制作用。将犬股动脉(供体)选择性暴露于SKF - 525A(50 μmol/L)60分钟,并不影响内皮被擦除的冠状动脉(生物测定组织)对基础EDRF以及对用ACh(10 - 1000 pmol)、ATP(1 - 100 nmol)或缓激肽(3 - 100 pmol)刺激的供体组织流出液的舒张反应。结果表明,SKF - 525A通过一种与内皮产生EDRF无关的平滑肌机制对内皮依赖性舒张表现出可逆性抑制作用。